Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery
Phase 4
Completed
- Conditions
- Cataract
- Interventions
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2010-03-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 64
- Registration Number
- NCT00870103
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
Phase 3
Withdrawn
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00862472
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: FID 114657Other: OPTIVE Lubricant Eye Drops
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00848068
Efficacy Study of Travoprost APS Versus TRAVATAN
Phase 3
Completed
- Conditions
- Open Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 371
- Registration Number
- NCT00848536
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 150
- Registration Number
- NCT00845195
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
Completed
- Conditions
- Cataract ExtractionCorneal Astigmatism
- Interventions
- Other: Visual performance measures
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2010-09-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00842231
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
Effect on Wound Healing of Vigamox Versus Cravit
Phase 4
Completed
- Conditions
- Cataract Extraction
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 79
- Registration Number
- NCT00840580
A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients
Phase 2
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: Hydroxypropyl Guar Galactomannan (HPGG) 0.25% ophthalmic gelDrug: Hydroxypropyl Guar Galactomannan Vehicle
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 427
- Registration Number
- NCT00840268
DuoTrav® Eye Drops As Replacement Therapy Program
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2012-09-20
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 128
- Registration Number
- NCT00828906
- Locations
- 🇨🇳
Contact Alcon for Trial Locations, Bejing, China
Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
Phase 4
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT00818805
© Copyright 2025. All Rights Reserved by MedPath